4000-520-616
欢迎来到免疫在线！(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
产品库 品牌馆 现货促销 技术交流 新闻动态 联系我们
MedChemExp
主营：主营：抑制剂、激动剂、API
咨询热线电话
4000-520-616
公司首页 公司介绍 产品中心 新闻动态 联系方式 在线下单
当前位置： 首页 > 产品中心 > Small_molecule > Medchemexpress/Riociguat（同义词：BAY 632521）/HY-14779/50mg
商品详细Medchemexpress/Riociguat（同义词：BAY 632521）/HY-14779/50mg
Medchemexpress/Riociguat（同义词：BAY 632521）/HY-14779/50mg
Medchemexpress/Riociguat（同义词：BAY 632521）/HY-14779/50mg
商品编号： HY-14779-10mM*1mLinDMSO
品牌： MedChemExp
市场价： ¥1580.00
美元价： 948.00
产地： 美国(厂家直采)
公司：
产品分类： 小分子
公司分类： Small_molecule
联系Q Q： 3392242852
电话号码： 4000-520-616
电子邮箱： info@ebiomall.com
立即询价
商品介绍
Riociguatisanoralstimulatorofsolubleguanylatecyclase(sGC),andusedinthetreatmentofpulmonaryhypertension.
Description

Riociguatisanoralstimulatorofsolubleguanylatecyclase(sGC),andusedinthetreatmentofpulmonaryhypertension.

InVitro

RiociguastimulatestherecombinantsGCconcentrationdependentlyfrom0.1to100 μMwithatwo-foldto73-foldeffectbyanNO-independentbuthaem-dependentmechanism[1]. Riociguatinhibitsplateletfunctioninwashedplateletsbutnotinwholeblood,andexertsnodirecteffectsoncontractilityandrelaxationofcardiacmyocytes[2].

InVivo

Riociguat(10mg/kg/d,p.o.)partiallyreversesthepulmonaryarterialhypertension,therighthearthypertrophyandthestructuralremodellingofthelungvasculatureinchronictreatmentofhypoxicmiceandMCT-injectedrats[1].

ClinicalTrial
ViewMoreCollapse
References

  • [1].SchermulyRT,etal.Expressionandfunctionofsolubleguanylatecyclaseinpulmonaryarterialhypertension.EurRespirJ.2008Oct;32(4):881-91.

    [2].SchermulyRT,etal.Riociguatforthetreatmentofpulmonaryhypertension.ExpertOpinInvestigDrugs.2011Apr;20(4):567-76.

PreparingStockSolutions
ConcentrationVolumeMass1mg5mg10mg
1mM2.3673mL11.8366mL23.6731mL
5mM0.4735mL2.3673mL4.7346mL
10mM0.2367mL1.1837mL2.3673mL
Pleaserefertothesolubilityinformationtoselecttheappropriatesolvent.
AnimalAdmiNISTration
[1]

Riociguatisformulatedin2%methylcellulose.

Mice[1]
Forchronicinterventionstudiesfourgroupsofmiceareused:controlmiceexposedfor35daystonormoxicgas(n=10);miceexposedfor21daystohypoxicgas(n=10);miceexposedfor35daystohypoxicgasandwhoreceivesthevehicle(2%methylcellulosesolution)fromday21today35(n=10);andmiceexposedfor35daystohypoxicgasandwhoreceivesBAY63-2521(10mg/kg)onceadaybyoralapplication(n=10)fromday21today35.Forcontinuousmeasurementof Prvs andcardiacfrequencybyrADIotelemetry,aseparategroupofmiceisexposedfor35daystohypoxicgasandreceivesBAY63-2521(10mg/kg)onceadaybyoralapplicationfromday21today35.Inordertoinvestigatevascularreactivityinisolatedmouselungs,anadditionaltwogroupsofanimalsareinvestigated:controlmice(n=12)andanimalsexposedfor21daystohypoxicconditions(n=12).
Rat[1]
RatsarerandomisedforchronicBAY63-2521treatment,21daysafterMCTinjection.TheexperimentalgroupsincludesratsthatreceivesBAY63-2521(10mg/kg)orvehicle(2%methylcellulosesolution)byoralapplication,onceperday.Ratsareexamineddailyandsubjectedtohaemodynamicmeasurementsandhistologicalassessmentatday35.MCEhasnotindependentlyconfirmedtheaccuracyofthesemethods.Theyareforreferenceonly.

References

  • [1].SchermulyRT,etal.Expressionandfunctionofsolubleguanylatecyclaseinpulmonaryarterialhypertension.EurRespirJ.2008Oct;32(4):881-91.

    [2].SchermulyRT,etal.Riociguatforthetreatmentofpulmonaryhypertension.ExpertOpinInvestigDrugs.2011Apr;20(4):567-76.

MolecularWeight

422.42

Formula

C₂₀H₁₉FN₈O₂

CASNo.

625115-55-1

Storage
Powder-20°C3years
 4°C2years
Insolvent-80°C6months
 -20°C1month
Shipping

RoomtemperatureincontinentalUS;mayvaryelsewhere

Solvent&Solubility

10mMinDMSO

*"<1 mg/ml"="" means="" slightly="" soluble="" or="" insoluble.="" "≥"="" means="" soluble,="" but="" saturation="">

Purity:99.73%